GloGlo
Curing and preventing type 1 diabetes
Hiring
About
Our mission: eradicate type 1 diabetes. GloGlo is building an AI-native therapeutics company focused on accelerating the discovery of treatments that can prevent, stop, and ultimately cure type 1 diabetes. We are developing AI research agents that continuously analyze scientific literature and biological datasets, generate and challenge hypotheses, design experiments, and run them in a wet lab to learn from experimental results. We are building a tight "in silico <> in vitro/vivo" feedback loop that helps us identify better targets, run experiments more efficiently, and move faster toward therapies for type 1 diabetes.
Topics
- Location
- San Francisco, CA, United States
- Team size
- 3 employees
- YC batch
- Winter 2024
- Status
- Active
- Stage
- Early stage
